Personalis, Inc. (PSNL)
Personalis Market Cap : 695.80M for April 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.674B |
| Celldex Therapeutics, Inc. | 2.254B |
| Plus Therapeutics, Inc. | 40.38M |
| Atossa Therapeutics, Inc. | 49.52M |
| Abeona Therapeutics, Inc. | 307.49M |
Market Cap Related Metrics
| PS Ratio | 8.521 |
| Price to Book Value | 2.664 |
| Price | 6.65 |
| Earnings Yield | -13.67% |